In Conquering Innovation Fatigue, we explain how “Patent Pain” is one of the external innovation fatigue factors that can slow down innovation. This factor includes actions by courts and lawmakers that add to the difficulty and expense of protecting intellectual property rights. A new aspect of this problem is the recent explosion in risk to …
Used Patents: A Potentially Deadly Part of Your Portfolio Read More »
Without wishing to be political, I have to say that I am worried about the future of innovation in light of “external innovation fatigue factors” that arise when government creates imposing barriers for innovators, especially for small businesses and lone entrepreneurs. As we note in Conquering Innovation Fatigue, the problem is often one of unintended …
The lifeblood of innovation is capital. Investment of capital is the primary difference between great ideas and great teams that go nowhere and those that change the world. From the airplane to the iPod, from wonder drugs to wonder software, innovation requires invested capital to bring concepts to commercial reality. Angel investors play a crucial …
In the game of chess, experienced players know that a move that looks tempting can often open up fatal weaknesses that deliver swift defeat later in the game. With experience, discipline, and solid strategic skills, good players can look several moves ahead and be aware of broad patterns and principles that can give one an …
Beware Unintended Innovation Killers from Laws, Regulations, and Corporate Policies Read More »
The road to innovation fatigue is paved with good intentions embodied in laws, regulations, and even corporate policies. Leaders at all levels must be aware of uninteded innovation-killing consequences that may follow from their good intentions. Staying in touch with the “voice of the innovator,” as we advocate in Conquering Innovation Fatigue, is vital in …
Beware the Unintended Innovation-Killing Consequences of Laws and Policies Read More »
One of the top nine “innovation fatigue factors” that we address in the book involves the challenges that stem from governmental policies and regulations. Chapter 14 explores this in detail, and urges government leaders and policy makers to listen to the “voice of the innovator” before they pass new laws or add new burdens that …
Innovation Fatigue from Excessive Regulation: Ford’s CEO Speaks Out Read More »
The Food and Drug Administration is taking aim at Cheerios, as Advertising Age reports. After two years of advertising the health benefits of the oats in Cheerios, General Mills now faces the wrath of the FDA. By claiming that it can lower cholesterol, no matter how many studies support that claim, General Mills is allegedly …